R. Le Scodan

发表

Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma: The French Phase II FFCD 9704-SFRO Trial

M. Ychou, J. Scoazec, F. Mornex, 2008, American journal of clinical oncology.

Treatment of the primary tumor in breast cancer patients with synchronous metastases.

R. Le Scodan, D. Ali, R. Scodan, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases

R. Le Scodan, D. Ali, D. Stevens, 2010, BMC Cancer.

Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.

M. Tubiana-Hulin, M. Gutiérrez, E. Brain, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death

M. Gutiérrez, E. Mouret‐Fourme, P. Chérel, 2011, BMC Cancer.

Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.

J. Pierga, S. Gerber, C. Bourgier, 2015 .

Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients.

P. Pommier, P. Céruse, S. Clippe, 2005, International journal of radiation oncology, biology, physics.

Profiling of EGFR mRNA and protein expression in 471 breast cancers compared with 10 normal tissues: A candidate biomarker to predict EGFR inhibitor effectiveness

S. Vacher, I. Bièche, R. Lidereau, 2012, International journal of cancer.

Identification of new candidate therapeutic target genes in triple-negative breast cancer.

Rosette Lidereau, Didier Meseure, S. Vacher, 2012, Genes & cancer.

Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.

E. Mouret‐Fourme, C. Massard, R. Le Scodan, 2007, International journal of radiation oncology, biology, physics.

Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.

J. Pierga, S. Gerber, C. Bourgier, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.

M. Bollet, F. Lerebours, R. Le Scodan, 2012, International journal of radiation oncology, biology, physics.

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review.

N. Girard, M. Ychou, J. Scoazec, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast mass with intense 99mTc-diphosphonate uptake revealing primary breast osteosarcoma.

F. Lerebours, J. Guinebretière, A. Langer, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

DNA repair gene expression and risk of locoregional relapse in breast cancer patients.

S. Vacher, I. Bièche, R. Lidereau, 2010, International journal of radiation oncology, biology, physics.

[Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience].

M. Bollet, F. Lerebours, R. Le Scodan, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?

E. Brain, R. Le Scodan, S. Lasry, 2010, International journal of radiation oncology, biology, physics.

Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

M. Bollet, F. Reyal, J. Pierga, 2010, International journal of radiation oncology, biology, physics.

[Prognostic factors for patients with brain metastases].

C. Massard, G. Noël, R. Le Scodan, 2013, Bulletin du cancer.

Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy.

R. Le Scodan, D. Stevens, L. Jouanneau, 2012, International journal of radiation oncology, biology, physics.

Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death

M. Gutiérrez, E. Mouret‐Fourme, P. Chérel, 2011, BMC Cancer.

[Role of lymph node irradiation in breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy: the René-Huguenin Cancer Center experience].

R. Le Scodan, D. Stevens, B. Lande, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.